TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 32901283

Group type: EXPERIMENTAL
Intervention: Rotta glucosamine (DONA powder sachets, 1500 mg/day)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Non-Rotta glucosamine (glucosamine sulphate 1500 mg one-a-day tablet)
Number of subjects: 14
Study: 32463382

Group type: EXPERIMENTAL
Intervention: Inhalation aromatherapy with lavender and sweet orange
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Aromatherapy massage with lavender and sweet orange
Number of subjects: 96

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 96
Study: 35533791

Group type: EXPERIMENTAL
Intervention: Short-course IV antibiotics (2 weeks)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Standard-course IV antibiotics (6 weeks)
Number of subjects: 60
Study: 33326848

Group type: EXPERIMENTAL
Intervention: Omadacycline
Number of subjects: 2112
Study: 33152285

Group type: EXPERIMENTAL
Intervention: HER2DX prognostic score
Number of subjects: 435
Study: 35876243

Group type: EXPERIMENTAL
Intervention: Moral disengagement intervention
Number of subjects: 1200

Group type: EXPERIMENTAL
Intervention: Social norms intervention
Number of subjects: 1200
Study: 34732523

Group type: EXPERIMENTAL
Intervention: GABA agonism
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 35365783

Group type: EXPERIMENTAL
Intervention: CP-LVH
Number of subjects: 2645

Group type: EXPERIMENTAL
Intervention: SL-LVH
Number of subjects: 2645

Group type: EXPERIMENTAL
Intervention: CV-LVH
Number of subjects: 2645

Group type: EXPERIMENTAL
Intervention: LVH
Number of subjects: 2645
Study: 33386021

Group type: COMPARATOR
Intervention: Microscope
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: 3D Exoscope
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: 2D Exoscope
Number of subjects: 22
Study: 32740306

Group type: EXPERIMENTAL
Intervention: Narrative intervention
Number of subjects: 80

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 80
Study: 35109491

Group type: EXPERIMENTAL
Intervention: Small group music therapy (GMT)
Number of subjects: 318

Group type: EXPERIMENTAL
Intervention: Recreational choir singing (RCS)
Number of subjects: 318

Group type: EXPERIMENTAL
Intervention: Combination of GMT and RCS
Number of subjects: 318

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 318

Group type: EXPERIMENTAL
Intervention: Neuropsychiatric symptoms
Number of subjects: 318

Group type: EXPERIMENTAL
Intervention: Quality of life
Number of subjects: 318

Group type: EXPERIMENTAL
Intervention: Care staff burden
Number of subjects: 318

Group type: EXPERIMENTAL
Intervention: Adverse events
Number of subjects: 318
Study: 32363616

Group type: EXPERIMENTAL
Intervention: Synbiotic supplementation (500 mg/day)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 33931405

Group type: EXPERIMENTAL
Intervention: Immune therapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 32067293

Group type: EXPERIMENTAL
Intervention: Mindful Yoga Intervention (MYI) added to Treatment as Usual (TAU)
Number of subjects: 171

Group type: COMPARATOR
Intervention: Treatment as Usual (TAU) alone
Number of subjects: 171
Study: 35679200

Group type: EXPERIMENTAL
Intervention: Email inquiries from simulated patients
Number of subjects: 725

Group type: EXPERIMENTAL
Intervention: Simulated patients with depression
Number of subjects: 725

Group type: EXPERIMENTAL
Intervention: Simulated patients who could pay full fee
Number of subjects: 725
Study: 34032866

Group type: EXPERIMENTAL
Intervention: Individual Placement and Support (IPS)
Number of subjects: 720

Group type: EXPERIMENTAL
Intervention: IPS supplemented with cognitive remediation (IPSE)
Number of subjects: 720

Group type: COMPARATOR
Intervention: Service as Usual
Number of subjects: 720
Study: 32125716

Group type: EXPERIMENTAL
Intervention: Consecutive controlled case series (CCCS) methodologies
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Randomized controlled trial combining SCEDs with randomized group designs
Number of subjects: 0
Study: 34915084

Group type: EXPERIMENTAL
Intervention: Neurofilament light chain dosage (NF‐L) at thresholds of 500 pg/ml and 1,200 pg/ml added to the modified ESICM/ERC 2021 algorithm.
Number of subjects: 49

Group type: COMPARATOR
Intervention: Unmodified ESICM/ERC 2021 algorithm without NF‐L.
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Neurofilament light chain (NF‐L) values for good versus poor outcomes.
Number of subjects: 49
Study: 32728814

Group type: EXPERIMENTAL
Intervention: Isotretinoin plus 420 nm IPL
Number of subjects: 47

Group type: COMPARATOR
Intervention: Isotretinoin alone
Number of subjects: 47
Study: 34847465

Group type: EXPERIMENTAL
Intervention: Simplified information intervention
Number of subjects: 20000

Group type: COMPARATOR
Intervention: Empathetic messages
Number of subjects: 20000

Group type: COMPARATOR
Intervention: Magnetic calendar reminder
Number of subjects: 20000

Group type: COMPARATOR
Intervention: Combination of interventions
Number of subjects: 20000
Study: 32846798

Group type: EXPERIMENTAL
Intervention: Intravenous tranexamic acid (TXA) administration [1 g] before skin incision
Number of subjects: 100

Group type: COMPARATOR
Intervention: Normal saline (control group)
Number of subjects: 100
Study: 35610657

Group type: EXPERIMENTAL
Intervention: Endoscopic management (EG)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Surgical management (SG)
Number of subjects: 100
Study: 34268723

Group type: EXPERIMENTAL
Intervention: Mavacamten
Number of subjects: 251

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 251
Study: 35451381

Group type: EXPERIMENTAL
Intervention: Mudan granules
Number of subjects: 93

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 93
Study: 34002563

Group type: EXPERIMENTAL
Intervention: Gel plaster
Number of subjects: 63

Group type: COMPARATOR
Intervention: Placebo plaster
Number of subjects: 63
Study: 32694053

Group type: EXPERIMENTAL
Intervention: Splenic characteristic prognostic model
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Splenic characteristics
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Age
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Tumor location
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: pTNM stage
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Prognostic prediction model combined with splenic characteristics
Number of subjects: 0
Study: 35158465

Group type: EXPERIMENTAL
Intervention: Inebilizumab
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Inebilizumab (AQP4-/MOG+ subset)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Inebilizumab (AQP4-/MOG- subset)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study: 33435919

Group type: EXPERIMENTAL
Intervention: Enriched Music-supported Therapy (eMST)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (home-based exercises utilizing the Graded Repetitive Arm Supplementary Program - GRASP)
Number of subjects: 60
Study: 34236037

Group type: EXPERIMENTAL
Intervention: Ultrasound renal denervation (RDN)
Number of subjects: 33
Study: 34979513

Group type: EXPERIMENTAL
Intervention: Levetiracetam (250 mg to a maximum of 1,500 mg)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Levetiracetam (250 mg to a maximum of 1,500 mg) and Placebo
Number of subjects: 72
Study: 33449316

Group type: EXPERIMENTAL
Intervention: Informed consent process
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Readability of informed consent documents
Number of subjects: 10
Study: 32311884

Group type: EXPERIMENTAL
Intervention: Prediction scoring system for hypoxemia
Number of subjects: 148
Study: 34599719

Group type: EXPERIMENTAL
Intervention: IPOM
Number of subjects: 258

Group type: EXPERIMENTAL
Intervention: IPOM plus
Number of subjects: 258

Group type: EXPERIMENTAL
Intervention: IPOM plus + AVCS
Number of subjects: 258
Study: 33707626

Group type: EXPERIMENTAL
Intervention: Genetic prediction based on selected subsets of SNPs from GWAS results
Number of subjects: 14827

Group type: EXPERIMENTAL
Intervention: Common SNPs with the most captured prediction accuracy in the selected sets
Number of subjects: 14827

Group type: EXPERIMENTAL
Intervention: Small number of SNPs obtained from GWAS results
Number of subjects: 14827
Study: 32311006

Group type: EXPERIMENTAL
Intervention: Men who used alcohol before suicide (12.6%)
Number of subjects: 242

Group type: EXPERIMENTAL
Intervention: Married status, mental disorder, depressive symptoms, hopelessness, impulsivity, loneliness, social support, family function, quality of life
Number of subjects: 242

Group type: EXPERIMENTAL
Intervention: Chronic physical illness and functions of daily living
Number of subjects: 242

Group type: EXPERIMENTAL
Intervention: Depressive symptoms and hopelessness
Number of subjects: 242
Study: 36415961

Group type: EXPERIMENTAL
Intervention: Long-term methimazole (LT-MMI)
Number of subjects: 130

Group type: COMPARATOR
Intervention: Radioactive iodine (RAI)
Number of subjects: 130
Study: 33938135

Group type: EXPERIMENTAL
Intervention: Low-fat diet (LF)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Mediterranean-low carbohydrate diet (MED/LC)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Physical activity (PA+)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Physical activity (PA−)
Number of subjects: 120
Study: 35844456

Group type: EXPERIMENTAL
Intervention: Comfortable nursing mode based on optimized MIoT
Number of subjects: 70

Group type: COMPARATOR
Intervention: Comfortable nursing mode
Number of subjects: 70
Study: 33902317

Group type: EXPERIMENTAL
Intervention: Tai Chi awareness and therapeutic option consideration
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Recommendation frequency of Tai Chi
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Factors affecting recommendation of Tai Chi
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Suggestions for increasing Tai Chi uptake
Number of subjects: 15
Study: 33492374

Group type: EXPERIMENTAL
Intervention: Usual care plus an automated series of 9 educational or reminder text messages in the week prior to scheduled colonoscopy
Number of subjects: 753

Group type: COMPARATOR
Intervention: Usual care (written instructions and nurse telephone call)
Number of subjects: 753

Group type: EXPERIMENTAL
Intervention: Usual care plus an automated series of 9 educational or reminder text messages
Number of subjects: 753
Study: 32968274

Group type: EXPERIMENTAL
Intervention: Presence of a high-status car (intervention)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo condition (control)
Number of subjects: 0
Study: 32097392

Group type: EXPERIMENTAL
Intervention: Argon plasma coagulation (APC) treatment offered in 96% of cases
Number of subjects: 114
Study: 33852730

Group type: EXPERIMENTAL
Intervention: Text messaging intervention (TMI) in addition to group counseling, nicotine patches, and written material; Duration: 6 weeks
Number of subjects: 77

Group type: COMPARATOR
Intervention: Standard care (group counseling, nicotine patches, and written material)
Number of subjects: 77
Study: 33130494

Group type: EXPERIMENTAL
Intervention: Intralesional curettage with cement filled plus fixator
Number of subjects: 14

Group type: COMPARATOR
Intervention: Distal femur resection with tumorous prosthesis replaced
Number of subjects: 14
Study: 33731649

Group type: EXPERIMENTAL
Intervention: 2-mile run
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: 4-mile run
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Overall runs (2-mile and 4-mile)
Number of subjects: 30
Study: 34903344

Group type: EXPERIMENTAL
Intervention: Drug-eluting stents (DES) used in 76% of BVS-ISR patients
Number of subjects: 117

Group type: EXPERIMENTAL
Intervention: BVS-ISR
Number of subjects: 117

Group type: COMPARATOR
Intervention: DES in BVS-ISR
Number of subjects: 117
Study: 32522268

Group type: EXPERIMENTAL
Intervention: Type 1 Modic Changes (n = 118)
Number of subjects: 180

Group type: COMPARATOR
Intervention: Type 2 Modic Changes (n = 62)
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Positive Springing test
Number of subjects: 180
Study: 35574656

Group type: EXPERIMENTAL
Intervention: Early circumcision (within 24 hours of delivery)
Number of subjects: 148

Group type: EXPERIMENTAL
Intervention: Intermediate circumcision (between 24 to 72 hours of age)
Number of subjects: 148

Group type: EXPERIMENTAL
Intervention: Late circumcision (between 1 and 3 weeks of age)
Number of subjects: 148
Study: 34675311

Group type: EXPERIMENTAL
Intervention: Prewarming for 15 minutes
Number of subjects: 297

Group type: EXPERIMENTAL
Intervention: Prewarming for 30 minutes
Number of subjects: 297

Group type: EXPERIMENTAL
Intervention: Prewarming for 45 minutes
Number of subjects: 297

Group type: COMPARATOR
Intervention: No prewarming (Control group)
Number of subjects: 297
Study: 34098214

Group type: EXPERIMENTAL
Intervention: High-protein group (HPG) - 25% daily calorie of protein
Number of subjects: 70

Group type: COMPARATOR
Intervention: Regular-protein group (RPG) - 15% daily calorie of protein
Number of subjects: 70
Study: 32325320

Group type: EXPERIMENTAL
Intervention: Early transplanting and applying irrigation
Number of subjects: 109

Group type: EXPERIMENTAL
Intervention: Farmers' perceptions of salinity
Number of subjects: 109

Group type: EXPERIMENTAL
Intervention: Farmers' awareness of salinity
Number of subjects: 109

Group type: EXPERIMENTAL
Intervention: Farmers' interpretation of salinity levels
Number of subjects: 109
Study: 34117153

Group type: EXPERIMENTAL
Intervention: Early drain removal (EDR)
Number of subjects: 312

Group type: COMPARATOR
Intervention: Routine drain removal (RDR)
Number of subjects: 312
Study: 33323802

Group type: EXPERIMENTAL
Intervention: Prophylactic antibiotics
Number of subjects: 3819

Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 3819
Study: 34134881

Group type: EXPERIMENTAL
Intervention: Extended-release injectable naltrexone before release (BR)
Number of subjects: 146

Group type: COMPARATOR
Intervention: Referral to treatment after release (AR)
Number of subjects: 146
Study: 32345253

Group type: COMPARATOR
Intervention: SMAQ (Simplified Medication Adherence Questionnaire) at T1 (baseline)
Number of subjects: 926

Group type: COMPARATOR
Intervention: SMAQ (Simplified Medication Adherence Questionnaire) at T2 (follow-up)
Number of subjects: 926

Group type: COMPARATOR
Intervention: SMAQ items 1 to 6
Number of subjects: 926

Group type: EXPERIMENTAL
Intervention: Measurement invariance of SMAQ
Number of subjects: 926
Study: 35184889

Group type: EXPERIMENTAL
Intervention: CROSS strategy
Number of subjects: 100

Group type: COMPARATOR
Intervention: Surgery alone
Number of subjects: 100

Group type: COMPARATOR
Intervention: Perioperative chemotherapy
Number of subjects: 100
Study: 33550268

Group type: EXPERIMENTAL
Intervention: Online intervention plus usual care
Number of subjects: 303

Group type: COMPARATOR
Intervention: Usual eczema care alone
Number of subjects: 303
Study: 32147082

Group type: EXPERIMENTAL
Intervention: Acupuncture treatment plus conventional treatment
Number of subjects: 134

Group type: COMPARATOR
Intervention: Conventional treatment only
Number of subjects: 134
Study: 33957854

Group type: EXPERIMENTAL
Intervention: Influvac® Tetra (subunit, inactivated influenza vaccine)
Number of subjects: 480

Group type: COMPARATOR
Intervention: VaxiFlu‐4 (split virion, inactivated influenza vaccine)
Number of subjects: 480
Study: 33169944

Group type: EXPERIMENTAL
Intervention: 37% carbamide peroxide (CP) for 30 min/day
Number of subjects: 80

Group type: COMPARATOR
Intervention: 10% carbamide peroxide (CP) for 4 h/day
Number of subjects: 80
Study: 33310500

Group type: COMPARATOR
Intervention: Bilateral ECT (BT)
Number of subjects: 91

Group type: EXPERIMENTAL
Intervention: Right Unilateral ECT (RUL)
Number of subjects: 91
Study: 35973226

Group type: EXPERIMENTAL
Intervention: Novel antimicrobial wound gel system
Number of subjects: 1500

Group type: COMPARATOR
Intervention: Standard of care (SOC)
Number of subjects: 1500
Study: 33958432

Group type: EXPERIMENTAL
Intervention: Transbronchial mediastinal cryobiopsy
Number of subjects: 197

Group type: COMPARATOR
Intervention: Endobronchial ultrasound‐guided transbronchial needle aspiration (EBUS‐TBNA)
Number of subjects: 197

Group type: EXPERIMENTAL
Intervention: Transbronchial mediastinal cryobiopsy and EBUS‐TBNA
Number of subjects: 197
Study: 32306029

Group type: EXPERIMENTAL
Intervention: Genetic correlation analysis using cross‐trait linkage disequilibrium (LD) score regression
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Mendelian randomization
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Independent genome‐wide association study (GWAS) replication
Number of subjects: 0
Study: 35779194

Group type: EXPERIMENTAL
Intervention: Lasmiditan 200 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: CNS-CTEAE
Number of subjects: 0
Study: 33951477

Group type: EXPERIMENTAL
Intervention: Acute intermittent hypoxia (AIH); 15, 1-min episodes (hypoxia: 10.3% O2) interspersed with room air breathing (1.5 min, 21% oxygen)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Sham (21% O2)
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: AIH
Number of subjects: 17
Study: 33277921

Group type: EXPERIMENTAL
Intervention: Stage III/IV periodontitis
Number of subjects: 404

Group type: EXPERIMENTAL
Intervention: Grade C periodontitis
Number of subjects: 404

Group type: EXPERIMENTAL
Intervention: Progression of periodontitis
Number of subjects: 404

Group type: EXPERIMENTAL
Intervention: Stage progression
Number of subjects: 404
Study: 35353636

Group type: EXPERIMENTAL
Intervention: Photobiomodulation therapy (PBMT) using gallium aluminum arsenide (GaAlAs) laser with parameters: wavelength of 810 nm, power of 0.5% ± 20% W, energy density of 4 J/cm2.
Number of subjects: 25

Group type: COMPARATOR
Intervention: Ibuprofen (control group).
Number of subjects: 25
Study: 33351989

Group type: EXPERIMENTAL
Intervention: 1.0% chlorhexidine gluconate solution preoperatively
Number of subjects: 322
Study: 32756878

Group type: EXPERIMENTAL
Intervention: Negative Condition (reading negative, discriminatory tweets)
Number of subjects: 57

Group type: COMPARATOR
Intervention: Neutral Condition (reading neutral tweets)
Number of subjects: 57
Study: 35316820

Group type: COMPARATOR
Intervention: Hyaluronic Acid (HA)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Leukocyte-Poor Platelet-Rich Plasma (LP-PRP)
Number of subjects: 70
Study: 32589290

Group type: EXPERIMENTAL
Intervention: Sitting for 3 hours
Number of subjects: 20
Study: 35942796

Group type: EXPERIMENTAL
Intervention: Tension-Free Vaginal Tape (TVT)
Number of subjects: 223

Group type: COMPARATOR
Intervention: Polyacrylamide Hydrogel (PAHG)
Number of subjects: 223
Study: 33143774

Group type: EXPERIMENTAL
Intervention: SFA-rich meal
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: MUFA-rich meal
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: PUFA-rich meal
Number of subjects: 0

Group type: COMPARATOR
Intervention: All meals
Number of subjects: 0
Study: 32564466

Group type: EXPERIMENTAL
Intervention: Laparoscopic total mesorectal excision (LTME) + transanal ISR
Number of subjects: 26

Group type: COMPARATOR
Intervention: Laparoscopic low anterior resection (Control)
Number of subjects: 26
Study: 36112791

Group type: EXPERIMENTAL
Intervention: Visual training intervention group (n=52)
Number of subjects: 110

Group type: COMPARATOR
Intervention: Control group (n=58)
Number of subjects: 110
Study: 35737699

Group type: EXPERIMENTAL
Intervention: Laser-based cavity preparation with acid etching (test group I, n = 21)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Laser-based cavity preparation without acid etching (test group II, n = 21)
Number of subjects: 75

Group type: COMPARATOR
Intervention: Conventional diamond burs preparation (control group, n = 33)
Number of subjects: 75
Study: 33453391

Group type: EXPERIMENTAL
Intervention: Niraparib (300 mg/day or 200 mg/day based on body weight and platelet count)
Number of subjects: 265

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 265

Group type: EXPERIMENTAL
Intervention: Niraparib
Number of subjects: 265
Study: 32078170

Group type: EXPERIMENTAL
Intervention: Transnasal humidified rapid-insufflation ventilatory exchange (THRIVE)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Conventional ventilation (TI or supraglottic high-frequency JV)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: THRIVE
Number of subjects: 20

Group type: COMPARATOR
Intervention: Conventional ventilation
Number of subjects: 20
Study: 35467580

Group type: EXPERIMENTAL
Intervention: Virtual Reality (VR) group
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Physical Simulation (PS) group
Number of subjects: 21

Group type: COMPARATOR
Intervention: Reading/Video control group
Number of subjects: 21
Study: 33610422

Group type: EXPERIMENTAL
Intervention: 1000 mg resveratrol daily for 3 months
Number of subjects: 78

Group type: COMPARATOR
Intervention: 1000 mg placebo daily for 3 months
Number of subjects: 78
Study: 34402090

Group type: EXPERIMENTAL
Intervention: Aerobic exercise group (n=54)
Number of subjects: 81

Group type: COMPARATOR
Intervention: Attention control group (n=27)
Number of subjects: 81
Study: 36045021

Group type: EXPERIMENTAL
Intervention: CD20-targeting agents
Number of subjects: 2428

Group type: COMPARATOR
Intervention: No CD20-targeting agents
Number of subjects: 2428

Group type: COMPARATOR
Intervention: B-symptoms
Number of subjects: 2428

Group type: COMPARATOR
Intervention: Elevated LDH
Number of subjects: 2428

Group type: COMPARATOR
Intervention: Low hemoglobin
Number of subjects: 2428
Study: 34815288

Group type: EXPERIMENTAL
Intervention: Human breast milk-based fortifier
Number of subjects: 222

Group type: COMPARATOR
Intervention: Bovine protein-based fortifier
Number of subjects: 222
Study: 35258443

Group type: EXPERIMENTAL
Intervention: Meropenem 2 g every 8 hours (TID)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Meropenem 2 g TID plus rifampin at 20 mg/kg once daily
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Meropenem 1 g TID
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Meropenem 3 g once daily
Number of subjects: 60
Study: 36011833

Group type: EXPERIMENTAL
Intervention: Cognitive−physical dual‐task training (n = 29)
Number of subjects: 58

Group type: COMPARATOR
Intervention: Functional balance training (n = 29)
Number of subjects: 58
Study: 32143655

Group type: EXPERIMENTAL
Intervention: ICU diary
Number of subjects: 126

Group type: COMPARATOR
Intervention: Usual care (Control)
Number of subjects: 126
Study: 32860696

Group type: EXPERIMENTAL
Intervention: High frequency chest wall oscillation and conventional chest physical therapy (breathing exercises, early ambulation, and cough training) thrice per week for 8 weeks
Number of subjects: 60

Group type: COMPARATOR
Intervention: Traditional chest physical therapy (breathing exercises, early ambulation, and cough training) thrice per week for 8 weeks
Number of subjects: 60